Photo of Yamini V. Virkud, MD

Yamini V. Virkud, MD

  • Assistant in Pediatrics


Accepting New Patients




Centers & Specialties

MassGeneral Hospital for Children

Clinical Interests
  • Food allergy
  • Allergic gastrointestinal disease
  • Allergic rhinitis
  • Asthma
  • Urticaria
  • Immunodeficiency syndromes
  • Allergies
Medical Education
  • MD, Washington University School of Medicine in St. Louis
  • Residency, St. Louis Children's Hospital
  • Fellowship, Duke University Medical Center
Board Certifications
  • Pediatrics
  • Allergy & Immunology
Foreign Languages
  • Marathi
  • Hindi
  • Boston: Massachusetts General Hospital
Insurances Accepted
  • Aetna Health Inc.
  • AllWays Health (NHP) - ACD
  • AllWays Health (NHP) - PBO
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • BMC HealthNet Mass Health MCO/ACO
  • Cigna (PAL #'s)
  • Commonwealth Care Alliance
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • Maine Community Health Options (MCHO)
  • MassHealth
  • Medicare
  • Medicare - ACD
  • OSW - Connecticut
  • OSW - New Hampshire
  • OSW - Rhode Island
  • OSW - Vermont
  • Private Health Care Systems (PHCS)
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
  • Well Sense
  • Well Sense Pediatrics

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group
Provider Gender


Dr. Virkud received her undergraduate degree at Harvard University in Biochemical Sciences, completed her medical training at Washington University in St. Louis, and concurrently obtained a Masters in Biology and Biomedical Sciences under the mentorship of Dr. John Constantino at Washington University. She completed her residency in pediatrics at St. Louis Children’s Hospital.  She trained at Duke University for her fellowship in Allergy and Immnology, where she researched under the mentorship of Dr. Wesley Burks, exploring the safety of investigational therapies for food allergy.  During this time, she also completed a clinical research fellowship at Duke Clinical Research Institute and a Masters of Public Health in Biostatistics at the University of North Carolina-Chapel Hill (UNC).  She currently is a pediatric allergist/immunologist at Massachusetts General Hospital for Children, an instructor at Harvard Medical School, and an associate epidemiologist at the Channing Division of Network Medicine, Brigham & Women’s Hospital.

Research & Publications

Research Summary

Dr. Virkud's research focuses on the  phenotyping different patients with food allergy and understanding the mechanisms of investigational therapies for food allergy.  Areas of active investigation include (1) safety of investigational therapies such as oral immunotherapy and predicting  which patients are most likely to benefit, (2) studying metabolite and RNA profiles of patients with food allergy, (3) investigating non-IgE mediated disease, like cow's milk protein intolerance in collaboration with the Gastrointestinal Microbiome and Allergic Proctocolitis (GMAP) Study .  She works  with numerous collaborators including from the Consortium for Food Allergy Research , the Broad Insititute, other members of the MGHfC Food Allergy Center and the Channing Division of Network Medicine.


View my most recent publications at PubMed

Virkud YV, Burks AW, Steele PH, Edwards LJ, Berglund JP, Jones SM, Scurlock AM, Perry TT, Pesek RD, Vickery BP. Novel Baseline Predictors of Allergic Side Effects During Peanut Oral Immunotherapy. J Allergy Clin Immunol. 2016. Epub ahead of print. PMID 27609653.

Burk CM, Dellon ES, Steele PH, Virkud YV, Kulis M, Burks AW, Vickery BP. Eosinophilic esophagitis during peanut oral immunotherapy with omalizumab.  J Allergy Clin Immunol Pract. 2016.  PMID 28017628.

Vickery BP, Berglund JP, Burk CM, Fine JP, Kim EH, Kim JI, Keet CA, Kulis M, Orgel, KG, Guo R, Steel, PH, Virkud YV, Ye P, Wright BL, Wood RA, Burks AW. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective. J Allergy Clin Immunol. 2017: 139(1):173-181. PMID: 27522159.

Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, Perry TT, Pesek RD, Sheikh S, Virkud Y, Smith PB, Shamji MH, Durham SR, Jones SM, Burks AW. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol. 2013; 133(2): 468-75. PMID: 24361082

Kelly RS, Virkud Y, Giorgio R, Celedón JC, Weiss ST, Lasky-Su J. Metabolomic profiling of lung function in Costa-Rican children with asthma. Biochim Biophys Acta. 2017; Epub ahead of print. PMID: 28188833

Virkud YV, Hornik CP, Benjamin DK, Laughon MM, Clark RH, Greenberg RG, Smith PB. Respiratory support for very low birth weight infants receiving dexamethasone.  The Journal of Pediatrics. 2017.  PMID: 28108103.

News & Events

  • Fewer food allergies means more precious childhood memories: Zach's story

    Growing up, Zach Leitao sometimes felt left out from social gatherings because of his severe food allergies. This past winter and spring, Zach, 8, recently passed food challenges, which means three of his previous food allergies are no longer a concern. Now the Leitaos feel more confident and safe knowing that Zach's world is open to a whole new set of culinary possibilities.


Pediatric Allergy and Immunology
275 Cambridge Street
Boston, MA 02114-3108
Phone: 617-726-8707
Fax: 617-724-3948

Back to Top